EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
EKG tracks a market cap-weighted index of globally-listed companies engaged in digital health technologies.
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 2.6 M
ASSETS UNDER MGMT
65 bp
EXPENSES
Fund Basics
| Inception date | Mar 22, 2022 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| IQVIA HOLDINGS INC | 8.4 % |
| INTUITIVE SURGICAL INC | 8.1 % |
| RESMED INC | 8.1 % |
| DEXCOM INC | 7.9 % |
| VEEVA SYSTEMS INC-CLASS A | 7.5 % |
| GLOBUS MEDICAL INC - A | 4.3 % |
| NATERA INC | 4.2 % |
| ALIGN TECHNOLOGY INC | 4.1 % |
| ILLUMINA INC | 4.1 % |
| GUARDANT HEALTH, INC. | 3.8 % |
Constituent Breakdown
| Number of holdings | 39 |
| Herfindahl-Hirschman Index | 481 |
| Wgt avg mkt cap (mns) | $34,619 |
| Large cap (>$10bn) | 73.2% |
| Mid cap ($2-10bn) | 21.3% |
| Small cap (<$2bn) | 4.7% |
| Developed mkts. | 98.7% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 95.0 % |
 |
NETHERLANDS | 3.7 % |
 |
COSTA RICA | 1.2 % |
Historical Performance
Standardized Performance (as of 03/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -14.6% | 3.7% | -2.2% | -1.8% | -- | -- | -- | -4.9% |
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | -- | 0.0% |
| Total Returns | -14.6% | 3.7% | -2.2% | -1.8% | -- | -- | -- | -4.9% | Ann. Volatility | 23.3% | 24.8% | 23.3% | 23.2% | -- | -- | -- | 27.1% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.99 | 58% |
| MSCI EAFE | 0.89 | 41% |
| MSCI Emg Mkts | 0.68 | 31% |
Liquidity Measures
| Avg. volume (000) | 0 |
| ADV traded (mns) | $0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.33% |
Technical Indicators
| 30d moving avg. (EMA) | $16.80 |
| Relative strength (RSI) | 50 |
| MACD/Signal | -0.05/-0.22 |
| Bollinger Bands (Upper/Lower) | $17.23/$15.69 |
| Short interest (% of AUM) | 1.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. EKG |
Expenses vs. EKG |
ALTAR Score™ vs. EKG |
|---|---|---|---|---|
| HEAL | Global X HealthTech ETF | 46.0% | -15 bp | -1.8% |
| FDHT | Fidelity Digital Health ETF | 26.7% | -26 bp | +1.1% |
| FMED | Fidelity Disruptive Medicine ETF | 22.3% | -15 bp | -2.4% |
| IHI | iShares U.S. Medical Devices ETF | 20.9% | -25 bp | +4.0% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 20.0% | +3 bp | +1.2% |
| GNOM | Global X Genomics & Biotechnology ETF | 18.8% | -15 bp | -4.3% |
| ARKG | ARK Genomic Revolution ETF | 17.0% | +10 bp | -2.6% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 16.6% | -30 bp | +2.7% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 16.4% | +10 bp | +0.3% |
| HELX | Franklin Genomic Advancements ETF | 15.8% | -15 bp | -2.1% |
Risk and Returns: EKG vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/21/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
1.2%
ALTAR SCORE™
11st
PERCENTILE
AVOID
ETFRC RATING
There are 587 funds in the Global Equity category with an average
ALTAR Score™ of 4.4% and a standard deviation
of 2.6%. EKG's ALTAR Score™ is approximately -1.2 standard
deviations above the category average. This places EKG in the 11st percentile
among funds in the category.
Sell-Side Consensus
$22.5
PRICE TARGET
+32.1%
UPSIDE